Elsevier to Include Doyma Spanish Medical Collection Titles on ScienceDirect

Tuesday, January 6, 2009 General News
Email Print This Page Comment bookmark
Font : A-A+

AMSTERDAM, January 6 Elsevier, the world'sleading publisher of scientific, technical and medical information productsand services, announced today that fifty prestigious titles from the ElsevierDoyma Spanish Medical Collection are available on ScienceDirect, its onlinescientific research platform.

Doyma, the leading Spanish language medical publisher acquired byElsevier in 2005, publishes approximately 5,000 high quality papers everyyear. The inclusion of Elsevier Doyma titles on ScienceDirect will allow moreresearchers across the world to access these articles.

To date, the Elsevier Doyma collection has only been available throughhttp://www.doyma.es and http://www.elsevierinstituciones.com and the narrowdistribution as well as Spanish language nature of these platforms haslimited access. The thousands of authors represented in the Elsevier Doymacollection will now enjoy greater market visibility, increasing the potentialfor research collaboration and recognition. In addition, many of the articleswill now include English abstracts benefiting non-Spanish speakingresearchers.

"The Elsevier Doyma Spanish Medical Collection represents a wide range ofhigh-quality journals," commented Rafael Sidi, Vice President, ProductManagement, ScienceDirect. "We are excited to include these titles onScienceDirect giving them more visibility in the global research community."

The addition of the Spanish Medical Collection follows the successfullaunch of Elsevier's Masson French Medical titles early 2008 and contributesto the evolution of the ScienceDirect platform into a comprehensive andcomplete source of global scientific knowledge.

About ScienceDirect

Over a quarter of the world's full text scientific, technical and medical(STM) peer-reviewed articles - managed by renowned editors, written byrespected authors and read by researchers from around the globe - areavailable in one place: ScienceDirect.

Elsevier's extensive and unique full-text collection covers authoritativetitles from the core scientific literature including high impact factortitles such as THE LANCET, Cell and Tetrahedron. Over nine million articlesare available online, including Articles in Press which offer online accessto recently accepted manuscripts. The critical mass of trusted informationavailable on ScienceDirect is unsurpassed. Coverage includes over 2,500journals published by Elsevier and dynamic linking to journals fromapproximately 2,000 STM publishers through CrossRef. An expanding program ofonline major reference works, handbooks, book series and over 4,400 eBooks inall fields of science seamlessly interlinks with primary research referencedin journal articles.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical andmedical information products and services. Working in partnership with theglobal science and health communities, Elsevier's 7,000 employees in over 70offices worldwide publish more than 2,000 journals and 1,900 new books peryear, in addition to offering a suite of innovative electronic products, suchas ScienceDirect (http://www.sciencedirect.com/), MD Consult(http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered inAmsterdam, The Netherlands and has offices worldwide. Elsevier is part ofReed Elsevier Group plc (http://www.reedelsevier.com/), a world-leadingpublisher and information provider. Operating in the science and medical,legal, education and business-to-business sectors, Reed Elsevier provideshigh-quality and flexible information solutions to users, with increasingemphasis on the Internet as a means of delivery. Reed Elsevier's tickersymbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK andENL (New York Stock Exchange).CONTACT: Malkie Bernheim/ Melanie Nadeau Padilla Speer Beardsley +1-212-752-8338 mbernheim@psbpr.com/ mnadeau@psbpr.com

SOURCE Elsevier & ScienceDirect

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store